Glenna B. Winnie

918 total citations
17 papers, 583 citations indexed

About

Glenna B. Winnie is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Molecular Medicine. According to data from OpenAlex, Glenna B. Winnie has authored 17 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 3 papers in Molecular Medicine. Recurrent topics in Glenna B. Winnie's work include Cystic Fibrosis Research Advances (9 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Neonatal Respiratory Health Research (3 papers). Glenna B. Winnie is often cited by papers focused on Cystic Fibrosis Research Advances (9 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Neonatal Respiratory Health Research (3 papers). Glenna B. Winnie collaborates with scholars based in United States and Greece. Glenna B. Winnie's co-authors include Robert G. Cowan, Mary Jane Thomassen, James M. Sherman, David M. Orenstein, Athanasios G. Kaditis, Fadi W. Abdul‐Karim, Thomas F. Boat, George A. Syrogiannopoulos, D Lewin and Jeanne Geiger‐Brown and has published in prestigious journals such as CHEST Journal, Infection and Immunity and The Journal of Pediatrics.

In The Last Decade

Glenna B. Winnie

16 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glenna B. Winnie United States 13 376 121 99 65 60 17 583
Philip Stanley United Kingdom 14 286 0.8× 75 0.6× 94 0.9× 46 0.7× 37 0.6× 30 824
Marek Wojciechowski Belgium 14 320 0.9× 143 1.2× 246 2.5× 40 0.6× 29 0.5× 66 796
Lucas L. Kulczycki United States 15 547 1.5× 51 0.4× 65 0.7× 50 0.8× 102 1.7× 30 793
Olof Kalm Sweden 18 349 0.9× 270 2.2× 65 0.7× 51 0.8× 19 0.3× 33 806
Michael Karplus Israel 17 266 0.7× 72 0.6× 41 0.4× 39 0.6× 113 1.9× 42 761
W. Theodore Bruns United States 10 760 2.0× 93 0.8× 152 1.5× 25 0.4× 23 0.4× 13 968
Fredric Kleinberg United States 14 254 0.7× 112 0.9× 56 0.6× 23 0.4× 33 0.6× 22 691
Martina Piras Italy 13 259 0.7× 127 1.0× 40 0.4× 18 0.3× 60 1.0× 25 620
Leonard Eisenfeld United States 17 239 0.6× 202 1.7× 34 0.3× 15 0.2× 51 0.8× 42 866
Tatiana Rozov Brazil 13 338 0.9× 37 0.3× 45 0.5× 52 0.8× 44 0.7× 29 473

Countries citing papers authored by Glenna B. Winnie

Since Specialization
Citations

This map shows the geographic impact of Glenna B. Winnie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenna B. Winnie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenna B. Winnie more than expected).

Fields of papers citing papers by Glenna B. Winnie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenna B. Winnie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenna B. Winnie. The network helps show where Glenna B. Winnie may publish in the future.

Co-authorship network of co-authors of Glenna B. Winnie

This figure shows the co-authorship network connecting the top 25 collaborators of Glenna B. Winnie. A scholar is included among the top collaborators of Glenna B. Winnie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenna B. Winnie. Glenna B. Winnie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
England, Sandra J., Daniel L. Picchietti, Barbara C. Fisher, et al.. (2011). l-Dopa improves Restless Legs Syndrome and periodic limb movements in sleep but not Attention-Deficit-Hyperactivity Disorder in a double-blind trial in children. Sleep Medicine. 12(5). 471–477. 49 indexed citations
2.
Rogers, Valerie E., D Lewin, Glenna B. Winnie, & Jeanne Geiger‐Brown. (2010). Polysomnographic Characteristics of a Referred Sample of Children with Sickle Cell Disease. Journal of Clinical Sleep Medicine. 6(4). 374–381. 58 indexed citations
3.
Kaditis, Athanasios G., Glenna B. Winnie, & George A. Syrogiannopoulos. (2007). Anti‐inflammatory pharmacotherapy for wheezing in preschool children. Pediatric Pulmonology. 42(5). 407–420. 49 indexed citations
4.
Kaditis, Athanasios G., Konstantinos I. Gourgoulianis, & Glenna B. Winnie. (2003). Anti‐inflammatory treatment for recurrent wheezing in the first five years of life. Pediatric Pulmonology. 35(4). 241–252. 14 indexed citations
5.
Orenstein, David M., et al.. (2002). Cystic fibrosis: A 2002 update. The Journal of Pediatrics. 140(2). 156–164. 81 indexed citations
6.
Winnie, Glenna B., et al.. (1994). Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. The Pediatric Infectious Disease Journal. 13(8). 716–719. 39 indexed citations
7.
Cowan, Robert G. & Glenna B. Winnie. (1993). Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: Correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis. Journal of Clinical Immunology. 13(5). 359–370. 11 indexed citations
8.
Winnie, Glenna B. & Robert G. Cowan. (1992). Association of Epstein-Barr virus infection and pulmonary exacerbations in patients with cystic fibrosis. The Pediatric Infectious Disease Journal. 11(9). 722–725. 8 indexed citations
9.
Winnie, Glenna B., et al.. (1991). Comparison of 6 and 8 hourly tobramycin dosing intervals in treatment of pulmonary exacerbations in cystic fibrosis patients. The Pediatric Infectious Disease Journal. 10(5). 381–385. 15 indexed citations
10.
11.
Winnie, Glenna B., Robert G. Cowan, & Nancy A. Wade. (1989). Intravenous immune globulin treatment of pulmonary exacerbations in cystic fibrosis. The Journal of Pediatrics. 114(2). 309–314. 35 indexed citations
12.
Sherman, James M., Glenna B. Winnie, Mary Jane Thomassen, Fadi W. Abdul‐Karim, & Thomas F. Boat. (1984). Time Course of Hemosiderin Production and Clearance by Human Pulmonary Macrophages. CHEST Journal. 86(3). 409–411. 99 indexed citations
13.
Thomassen, Mary Jane, Jeffrey D. Klinger, Glenna B. Winnie, et al.. (1984). Pulmonary cellular response to chronic irritation and chronic Pseudomonas aeruginosa pneumonia in cats. Infection and Immunity. 45(3). 741–747. 21 indexed citations
14.
Thomassen, Mary Jane, Catherine Demko, Glenna B. Winnie, & James M. Sherman. (1984). Function of Human Alveolar Macrophages From Normal Volunteers and Cigarette Smokers: Effect of Cystic Fibrosis Serum. Journal of Leukocyte Biology. 35(4). 345–355. 5 indexed citations
15.
Winnie, Glenna B., Dorr G. Dearborn, Jeffrey D. Klinger, & Mary Jane Thomassen. (1983). Phagocytosis ofPseudomonas aeruginosa by feline alveolar macrophages: Strain differences in nonimmune serum. Current Microbiology. 9(2). 63–67. 1 indexed citations
16.
Winnie, Glenna B., Jeffrey D. Klinger, James M. Sherman, & Mary Jane Thomassen. (1982). Induction of phagocytic inhibitory activity in cats with chronic Pseudomonas aeruginosa pulmonary infection. Infection and Immunity. 38(3). 1088–1093. 22 indexed citations
17.
Jacobstein, Mark D., Stephen S. Hirschfeld, Glenna B. Winnie, Carl F. Doershuk, & Jerome Liebman. (1981). Ventricular Interdependence in Severe Cystic Fibrosis. CHEST Journal. 80(4). 399–404. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026